Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jean-Pierre Yared, MD, is the Director of the Center for Critical Care Medicine in the Heart and Vascular Institute and a staff anesthesiologist in the Anesthesiology Institute at the Cleveland Clinic where he is on the staff of the Department of Cardiothoracic Anesthesia.
He is certified by the American Board of Anesthesiology and the American Board of Critical Care Medicine, and he has successfully completed the National Board Examination.
Dr. Yared specializes in cardiothoracic anesthesiology and critical care medicine. In addition, he has a specialty interest in the treatment of pulmonary hypertension and in modulation of the inflammatory response to cardiopulmonary bypass. He also focuses on clinical research and resident education.
A native of Lebanon, Dr. Yared received his medical degree from the American University of Beirut following an undergraduate degree in science. He continued his clinical training at the American University with an internship in pediatrics and residency training in general anesthesia. He then received fellowships in cardiac anesthesia and in critical care medicine from Cleveland Clinic. He was appointed to the Cleveland Clinic as a staff anesthesiologist in 1988.
Prior to his appointment to the Cleveland Clinic, Dr. Yared was Director of Cardiac Anesthesia and Post-Surgical Cardiac ICU at Dr. Fakeeh Hospital in Jeddah, Saudi Arabia, and attending anesthesiologist at Dr. Rizk Hospital in Beirut. He also had an academic appointment as Assistant Professor in the Department of Anesthesiology at the American University in Beirut.
Dr. Yared’s clinical research has focused primarily on studying the effects of various interventions for high-risk and cardiac surgery patients. He is currently receiving funding from the Population Health Research Institute as a co-investigator for a multi-center study on corticosteroids, initiated post-induction of anesthesia, in the management of coronary artery bypass graft patients requiring cardiopulmonary bypass.
He has authored or co-authored numerous articles and abstracts in medical journals such as Anesthesia and Analgesia, Journal of Cardiovascular Surgery and Intensive Care Medicine. He is the author of a chapter on hemodynamics and respiratory monitoring in a medical textbook on the critically ill patient, as well as co-author of other chapters related to his research and specialty interests. He has been an invited lecturer at international and national medical conferences and symposia.
Dr. Yared is a member of the American Society of Anesthesiologists, the Society of Critical Care Medicine, the American Society of Critical Care Anesthesiologists, the Society of Cardiovascular Anesthesiologists, and the Cleveland Society of Anesthesiologists.
cardiothoracic anesthesia, cardiovascular critical care, fellow and resident education,
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/3/2015, Dr. Yared has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.